Roberts M Scot has filed 54 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 222670 shares of Altimmune, Inc. ($ALT) on February 26, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | A | Stock Options (option to buy) | 222670 | $0.00 | 222,670.0000 | 88,104,132 | 9999.99% | 0.25% |
| Feb. 26, 2026 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | A | Restricted Stock Units | 95430 | $0.00 | 95,430.0000 | 88,104,132 | 9999.99% | 0.11% |
| Jan. 30, 2026 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 2859 | $5.60 | 101,811.0000 | 88,104,132 | 2.73% | 0.00% |
| Jan. 30, 2026 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 9275 | $0.00 | 104,670.0000 | 88,104,132 | 9.72% | 0.01% |
| Feb. 2, 2026 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 7775 | $0.00 | 115,153.0000 | 88,104,132 | 7.24% | 0.01% |
| Jan. 31, 2026 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | A | Common Stock, par value $0.0001 | 5567 | $3.07 | 107,378.0000 | 88,104,132 | 5.47% | 0.01% |
| Feb. 2, 2026 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 7775 | $0.00 | 0.0000 | 88,104,132 | 100.00% | 0.01% |
| Jan. 30, 2026 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 9275 | $0.00 | 9,275.0000 | 88,104,132 | 50.00% | 0.01% |
| Feb. 2, 2026 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 2329 | $5.55 | 112,824.0000 | 88,104,132 | 2.02% | 0.00% |
| Jan. 27, 2026 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 15850 | $0.00 | 47,550.0000 | 88,104,132 | 25.00% | 0.02% |
| Jan. 27, 2026 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 4748 | $6.18 | 95,395.0000 | 88,104,132 | 4.74% | 0.01% |
| Jan. 27, 2026 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 15850 | $0.00 | 100,143.0000 | 88,104,132 | 18.80% | 0.02% |
| Jan. 25, 2026 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 14600 | $0.00 | 88,666.0000 | 88,104,132 | 19.71% | 0.02% |
| Jan. 25, 2026 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 4373 | $5.50 | 84,293.0000 | 88,104,132 | 4.93% | 0.00% |
| Jan. 25, 2026 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 14600 | $0.00 | 29,200.0000 | 88,104,132 | 33.33% | 0.02% |
| July 31, 2025 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | A | Common Stock, par value $0.0001 | 846 | $3.14 | 74,066.0000 | 81,477,548 | 1.16% | 0.00% |
| Feb. 2, 2025 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 7775 | $0.00 | 75,536.0000 | 71,003,399 | 11.47% | 0.01% |
| Jan. 30, 2025 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 9275 | $0.00 | 62,921.0000 | 71,003,399 | 17.29% | 0.01% |
| Jan. 30, 2025 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 2709 | $7.00 | 60,212.0000 | 71,003,399 | 4.31% | 0.00% |
| Jan. 31, 2025 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | A | Common Stock, par value $0.0001 | 3184 | $5.18 | 63,396.0000 | 71,003,399 | 5.29% | 0.00% |
| Feb. 1, 2025 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 6166 | $0.00 | 69,562.0000 | 71,003,399 | 9.73% | 0.01% |
| Feb. 1, 2025 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 1801 | $6.64 | 67,761.0000 | 71,003,399 | 2.59% | 0.00% |
| Feb. 2, 2025 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 2316 | $6.64 | 73,220.0000 | 71,003,399 | 3.07% | 0.00% |
| Jan. 30, 2025 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 9275 | $0.00 | 18,550.0000 | 71,003,399 | 100.00% | 0.01% |
| Feb. 1, 2025 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 6166 | $0.00 | 0.0000 | 71,003,399 | 0.00% | 0.01% |
| Feb. 2, 2025 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 7775 | $0.00 | 7,775.0000 | 71,003,399 | 9999.99% | 0.01% |
| Jan. 25, 2025 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 14600 | $0.00 | 57,925.0000 | 71,003,399 | 33.70% | 0.02% |
| Jan. 25, 2025 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 4264 | $6.98 | 53,661.0000 | 71,003,399 | 7.36% | 0.01% |
| Jan. 25, 2025 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 14600 | $0.00 | 43,800.0000 | 71,003,399 | 50.00% | 0.02% |
| Jan. 27, 2025 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | A | Stock Options (option to buy) | 183600 | $0.00 | 183,600.0000 | 71,003,399 | 9999.99% | 0.26% |
| Jan. 27, 2025 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | A | Restricted Stock Units | 63400 | $0.00 | 63,400.0000 | 71,003,399 | 9999.99% | 0.09% |
| July 31, 2024 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | A | Common Stock, par value $0.0001 | 650 | $5.41 | 43,325.0000 | 70,924,371 | 1.52% | 0.00% |
| Feb. 1, 2024 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 6166 | $0.00 | 6,166.0000 | 53,246,937 | 50.00% | 0.01% |
| Feb. 1, 2024 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 6166 | $0.00 | 39,031.0000 | 53,246,937 | 18.76% | 0.01% |
| Feb. 1, 2024 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 1801 | $9.88 | 37,230.0000 | 53,246,937 | 4.61% | 0.00% |
| Feb. 2, 2024 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 7775 | $0.00 | 45,005.0000 | 53,246,937 | 20.88% | 0.01% |
| Feb. 2, 2024 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 2330 | $9.32 | 42,675.0000 | 53,246,937 | 5.18% | 0.00% |
| Feb. 2, 2024 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 7775 | $0.00 | 15,550.0000 | 53,246,937 | 33.33% | 0.01% |
| Jan. 30, 2024 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 2709 | $9.80 | 27,005.0000 | 53,246,937 | 9.12% | 0.01% |
| Jan. 31, 2024 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | A | Common Stock, par value $0.0001 | 5860 | $2.69 | 32,865.0000 | 53,246,937 | 21.70% | 0.01% |
| Jan. 30, 2024 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 9275 | $0.00 | 27,825.0000 | 53,246,937 | 25.00% | 0.02% |
| Jan. 30, 2024 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 9275 | $0.00 | 29,714.0000 | 53,246,937 | 45.38% | 0.02% |
| Jan. 25, 2024 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | A | Stock Options (option to buy) | 163200 | $0.00 | 163,200.0000 | 53,246,937 | 9999.99% | 0.31% |
| Jan. 25, 2024 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | A | Restricted Stock Units | 58400 | $0.00 | 58,400.0000 | 53,246,937 | 9999.99% | 0.11% |
| July 31, 2023 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | A | Common Stock, par value $0.0001 | 568 | $2.81 | 20,439.0000 | 50,691,558 | 2.86% | 0.00% |
| Feb. 2, 2023 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 7775 | $0.00 | 23,325.0000 | 46,926,349 | 25.00% | 0.02% |
| Feb. 2, 2023 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 2375 | $15.04 | 19,871.0000 | 46,926,349 | 10.68% | 0.01% |
| Feb. 2, 2023 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 7775 | $0.00 | 22,246.0000 | 46,926,349 | 53.73% | 0.02% |
| Feb. 1, 2023 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 6166 | $0.00 | 12,332.0000 | 46,926,349 | 33.33% | 0.01% |
| Feb. 1, 2023 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 2183 | $13.78 | 14,471.0000 | 46,926,349 | 13.11% | 0.00% |
| Feb. 1, 2023 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 6166 | $0.00 | 16,654.0000 | 46,926,349 | 58.79% | 0.01% |
| Jan. 31, 2023 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | A | Common Stock, par value $0.0001 | 1436 | $10.21 | 10,488.0000 | 46,926,349 | 15.86% | 0.00% |
| Jan. 30, 2023 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | A | Restricted Stock Units | 37100 | $0.00 | 37,100.0000 | 46,926,349 | 9999.99% | 0.08% |
| Jan. 30, 2023 | Altimmune, Inc. | $ALT | Roberts M Scot | Chief Scientific Officer | A | Stock Options (option to buy) | 105000 | $0.00 | 105,000.0000 | 46,926,349 | 9999.99% | 0.22% |